Evaluation of peri-implant crevicular fluid biomarkers and marginal bone loss in platform-switched and non-platform-switched implants: a randomised prospective clinical study

Not Applicable

Completed

• Conditions: missing teeth; dental implants, matrix metalloprotinases, gingival crevicular fluids, cytokines, diagnostics

• Registration Number: TCTR20200425004
• Lead Sponsor: istanbul university scientific research project

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2015-09-01
• Study Start: 2020-04-25
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 27

Inclusion Criteria

an implant site without acute infection or bone defects; a bone crest ≥7 mm; a full-mouth plaque score (modified plaque index [mPI]) and full-mouth bleeding score (bleeding on probing [BOP]) ≤25%; ≤10 cigarettes per day if a smoker; and a peri-implant keratinised tissue width ≥2 mm.

Exclusion Criteria

systemic medical conditions such as diabetes and any medication that could influence healing of soft or hard tissue.
full-mouth plaque score (modified plaque index [mPI]) and full-mouth bleeding score (bleeding on probing [BOP]) more than 25%; 10 and more cigarettes per day if a smoker; and a peri-implant keratinised tissue width less than 2 mm.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
PICF LTB4 levels 1 year Elisa

Secondary Outcome Measures

Name	Time	Method
PICF MMP8/TIMP1 levels 1 year Elisa